OMNOVA Solutions Inc

OMNOVA Solutions — Investor Presentation (February 2017)

34 slides from OMNOVA Solutions's investor presentation, Feb 13, 2017

  1. Slide 1: Why OMNOVA Solutions? A Look Forward 2016 Year End

    COMPANY CONFIDENTIAL Why OMNOVA Solutions? A Look Forward 2016 Year End Investor Presentation Global Innovator of Performance-Enhancing Chemistries and Surfaces

  2. Slide 2: Cautionary Statements

    COMPANY CONFIDENTIAL Cautionary Statements 2 Forward-Looking Statements This presentation includes descriptions of OMNOVA's current business, operations, assets and other matters affecting the Company as well as "forward-looking statements" as defined by federal securities laws. All forward-looking

  3. Slide 3: With OMNOVA Products... Diapers are more absorbent

    With OMNOVA Products... DIAPERS ARE MORE ABSORBENT.

  4. Slide 4: With OMNOVA Products... Restaurants and retail environments

    With OMNOVA Products... RESTAURANTS AND RETAIL ENVIRONMENTS LOOK BETTER, ONGER, AND COST LES ae

  5. Slide 5: With OMNOVA Products... Buildings

    With OMNOVA Products... BUILDINGS) OLD SAND CANBE ae R LIMATES AND C

  6. Slide 6: With OMNOVA Products...

    With OMNOVA Products... OF ce

  7. Slide 7: Countless consumer and commercial brands depend on OMNOVA

    COUNTLESS CONSUMER AND COMMERCIAL BRANDS DEPEND ON OMNOVA TO GAIN THAT SPECIAL EDGE IN PERFORMANCE. Automotive t ~ \ysFood Semvide) )

  8. Slide 8: OMNOVA Solutions: Global innovator of performance enhancing chemistries and surfaces

    COMPANY CONFIDENTIAL OMNOVA Solutions Global innovator of performance enhancing chemistries and surfaces 8 $760M* SALES 26% Performance Chemicals Latex Binders │ Acrylics │ Resins │Hollow Plastic Pigments │ Fluorosurfactants │ Opacifiers │ Bio-Based Polymers Engineered Surfaces Coated Fabrics │ Spec

  9. Slide 9: Well-Positioned for Strong Continued Earnings Momentum and Cash Generation

    COMPANY CONFIDENTIAL Well-Positioned for Strong Continued Earnings Momentum and Cash Generation 9 Near-term (2016-2017) drivers Medium to longer term (2016-2018+) drivers reversed trend in specialty businesses $0 $50 $100 $150 $200 2010 Adjusted EBITDA Paper / carpet latex erosion Growth in specialt

  10. Slide 10: Goals Reflect Continuing Transition To Specialty Focus

    COMPANY CONFIDENTIAL Goals Reflect Continuing Transition To Specialty Focus Adjusted Segment Operating Margin* 6.9% 8.9% Mid Teens *Non-GAAP adjusted values, GAAP reconciliation in the appendix. Excludes corporate expense. 10 2014 2015 Goal Growth: 2X Underlying Specialty Markets › Specialty Volume

  11. Slide 11: Our Value-Creating Strategic Priorities

    COMPANY CONFIDENTIAL Our Value-Creating Strategic Priorities How we'll get there 11 "One OMNOVA" Reduced complexity and drives consistency across global enterprise OPERATIONAL FINANCIAL Accelerate Growth In Specialty Businesses Expand Margins, Generate Cash In Mature Businesses Drive Improved Return

  12. Slide 12: Accelerate Growth In Specialty Businesses

    COMPANY CONFIDENTIAL Accelerate Growth In Specialty Businesses Grow specialty greater than underlying markets 12 Targeting Specialty Growth Markets › Higher growth, higher margin businesses › Strong position from which to build…significant opportunities to grow share › Footprint actions enhance spec

  13. Slide 13: Specialty Growth: Targeted Markets

    COMPANY CONFIDENTIAL Specialty Growth: Targeted Markets Targeting robust markets with demand for high performance, high margin products 13 % = Estimated Market Growth Rate *Market data based on internal estimates and OMNOVA’s place in the value chain. PC ES PC PC/ES PC PC E Common characteristics: h

  14. Slide 14: Diversifying Chemistries & Geographies

    COMPANY CONFIDENTIAL Diversifying Chemistries & Geographies Increased access to specialty markets Other Chemistries SB Latex Asia Europe N. America Diversifying Chemistries & Markets Total OMNOVA Global Expansion 14 Total Company Total Company 20% 80% 73% 27% Pre-2010 2016 11% 87% 2% 11% 87% 17% 23%

  15. Slide 15: Market & Customer Driven Innovation Portfolio

    COMPANY CONFIDENTIAL 15 Market & Customer Driven Innovation Portfolio Transforming the portfolio to be a leading provider of Sustainable, Greener, SMARTer innovative solutions Targeting vitality index >27% at specialty margins Voice of the customer Sustainable Solutions SMART technologies Disruptive

  16. Slide 16: Strategic Alliances and M&A to Accelerate Specialty Growth

    COMPANY CONFIDENTIAL Strategic Alliances and M&A to Accelerate Specialty Growth 16 STRATEGIC ALLIANCES M&A Close-In Emulsion Polymers • N.A. SB consolidation • Specialty acrylics Adjacencies Technology Operations & Supply Chain Commercial • Joint development agreements • License technology • Geograp

  17. Slide 17: Expand Margins, Generate Cash In Mature Businesses

    COMPANY CONFIDENTIAL Strengthening Customer Relationships › Capture growth in carpet and non-carpet flooring › Greater focus on higher growth specialty paper/packaging segments › Value-based pricing Expand Margins, Increase Cash Generation In Mature Businesses 17 Lowering Our Cost Base › Operational

  18. Slide 18: Manufacturing Realignment and SG&A Restructuring

    COMPANY CONFIDENTIAL 18 Manufacturing Realignment and SG&A Restructuring Work substantially completed during 2Q 2016 – Savings on track ~300M lbs N. America SB capacity reduction >90% N. America SB capacity utilization (previously 62%) Realigned Manufacturing Footprint through facility closures, cap

  19. Slide 19: Drive Improved Return On Investment

    COMPANY CONFIDENTIAL Drive Improved Return On Investment Driving to returns in excess of cost of capital 19 Exploit Operational Leverage › ROIC in 2017 incentives › Increased return on innovation › Increased capacity utilization › Footprint optimization › Repurposing to specialty › Fixed cost manage

  20. Slide 20: Deploy a Balanced Capital Allocation Policy

    COMPANY CONFIDENTIAL Deploy a Balanced Capital Allocation Policy Strategy 20 Strategic Growth Investments › Bolt-on M&A to support specialty businesses › Funded by growth in EBITDA and cash flow Disciplined Approach to Capital Spending › Focused on key growth markets De-Levering Business › Targeting

  21. Slide 21: Record of Cash Generation and De-Leveraging

    COMPANY CONFIDENTIAL 21 Consistent deleveraging since acquisition Record of Cash Generation and De-Leveraging Refinancing completed in Q3 2016 Reduced gross debt by ~$90M since 2011 Disciplined balance sheet management › Redeemed $50M of bonds in November 2014 and › November 2015 respectively with e

  22. Slide 22: Capital Structure / Liquidity / Net Leverage

    COMPANY CONFIDENTIAL Capital Structure / Liquidity / Net Leverage Liquidity Revolver $63 • Balance Drawn • Letters of Credit $0 $0 Remaining Capacity $63 Cash** $78 Total Liquidity $141 22 As of November 30, 2016 (In millions) Weighted average debt cost ~ 5.8% / sufficient liquidity Net Leverage Rat

  23. Slide 23: History of Taking Decisive Action

    COMPANY CONFIDENTIAL 23 History of Taking Decisive Action Strategic portfolio actions to drive shareholder value Proactive actions partially offset headwinds in performance materials businesses • Access to fast- growing Asian markets • Upgrade capabilities • Low-cost manufacturing • Expand global ma

  24. Slide 24: Why OMNOVA Solutions?

    COMPANY CONFIDENTIAL › Exciting opportunities to grow higher margin Specialty businesses › Strengthened innovation and commercial excellence process › Positive momentum in margin expansion, earnings growth and cash generation › Significantly lowered cost base and reconfigured manufacturing footprint

  25. Slide 25: OMNOVA Solutions

    OMNOVAY SOLUTIONS.

  26. Slide 26: SB Raw Material Costs and Performance Features Contribute to Cost-in-Use Advantage

    COMPANY CONFIDENTIAL SB Raw Material Costs and Performance Features Contribute to Greater Cost-in-Use Advantage SB latex maintains an advantaged position 26 0 25 50 75 100 125 150 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Ce n ts p e r l b . Compa

  27. Slide 27: Total Company Sales by End Market

    COMPANY CONFIDENTIAL Total Company Sales by End Market 27 Refurbishment & new construction 40% Paper and packaging 15% Transportation 19% Industrial / Other 12% Personal hygiene 8% Oilfield 6% Note: Financials breakdown as of 2016 FYE. Financials inclusive of Indian rubber business sold in Q1 2016.

  28. Slide 28: Non-GAAP financial measures definitions

    COMPANY CONFIDENTIAL This presentation includes Adjusted Segment Operating Profit, Adjusted Segment EBITDA, Adjusted Income from Continuing Operations Before Income Taxes, Adjusted Consolidated EBITDA and other financial measures which are Non-GAAP financial measures as defined by the Securities and

  29. Slide 29: Appendix – Reconciliation of Reported Segment Sales and Operating Profit

    COMPANY CONFIDENTIAL Appendix 1 – Reconciliation of Reported Segment Sales and Operating Profit to Net Sales and Net (Loss) Income 29 Three Months Ended Year Ended November 30, November 30, (Dollars in millions) 2016 2015 2016 2015 Net Sales Performance Chemicals Performance Materials $ 68.6 $ 78.1

  30. Slide 30: Appendix – Performance Chemicals

    COMPANY CONFIDENTIAL Appendix 2 – Performance Chemicals 30 Year Ended November 30, (Dollars in millions) 2012 2013 2014 2015 2016 Sales $ 864.5 $ 773.0 $ 746.5 $ 608.1 $ 548.8 Segment Operating Profit $ 89.6 $ 64.1 $ 46.2 $ 15.9 $ 55.9 Management Excluded Items Restructuring and severance - 2.1 0.5

  31. Slide 31: Appendix – Engineered Surfaces

    COMPANY CONFIDENTIAL Appendix 3 – Engineered Surfaces 31 Year Ended November 30, (Dollars in millions) 2012 2013 2014 2015 2016 Sales $ 261.0 $ 245.1 $ 241.1 $ 229.9 $ 211.1 Segment Operating Profit $ 3.8 $ 15.6 $ 19.2 $ 18.9 $ 12.4 Management Excluded Items Restructuring and severance 1.5 3.0 0.2 1

  32. Slide 32: Appendix – OMNOVA Consolidated

    COMPANY CONFIDENTIAL Appendix 4 – OMNOVA Consolidated 32 (Dollars in millions except per share data) 2012 2013 2014 2015 2016 Sales $ 1,125.5 $ 1,018.1 $ 987.4 $ 838.0 $ 759.9 P C A djusted Segment Operat ing P ro f it $ 89.6 $ 67.1 $ 49.9 $ 52.2 $ 62.4 ES A djusted Segment Operat ing P ro f it 9.3

  33. Slide 33: Appendix – Adjusted Return on Invested Capital

    COMPANY CONFIDENTIAL Appendix 5 – Adjusted Return on Invested Capital 33 Twelve Months Ended November 30, Adjusted Net Operating Profit after Tax 2016 2015 2014 Adjusted Income from Continuing Operations $ 22.2 $ 16.5 $ 12.9 Interest add back excluding debt premium and additional interest 22.7 27.3

  34. Slide 34: OMNOVA Solutions

    OMNOVAY _ SOLUTIONS:

Omnova Solutions — Investor Presentation (February 2017) on 6ix